Press Releases | Greenwich LifeSciences, Inc. (GLSI) | GP2

Nov 10, 2021 7:00am EST

Greenwich LifeSciences Provides Clinical Update on Upcoming Phase III Clinical Trial, FLAMINGO-01

Nov 09, 2021 6:00am EST

Greenwich LifeSciences Provides Updated Corporate Presentation and Webcasts

Sep 28, 2021 6:00am EDT

Greenwich LifeSciences to Partner with Susan G. Komen Race for the Cure Houston

Sep 27, 2021 6:00am EDT

Greenwich LifeSciences to Present at the Benzinga Healthcare Small Cap Conference

Sep 23, 2021 6:00am EDT

Greenwich LifeSciences to Present at the Cantor Global Healthcare Conference

Sep 13, 2021 6:00am EDT

Greenwich LifeSciences to Present at H.C. Wainwright 23rd Annual Global Investment Conference

Sep 09, 2021 6:00am EDT

Greenwich LifeSciences Provides Updates on Recent and Upcoming Developments

Sep 07, 2021 6:00am EDT

Greenwich LifeSciences to Participate in Citi’s 16th Annual Biopharma Virtual Conference

Jun 08, 2021 6:00am EDT

Greenwich LifeSciences Set to Join Russell 2000® Index

Jun 07, 2021 6:30am EDT

Greenwich LifeSciences Publishes Additional Positive Safety Data from GP2 Phase IIb Trial at ASCO 2021, Confirming that GP2 Treatment to Prevent Metastatic Breast Cancer Recurrence is Well Tolerated

Previous
1
2
3
4
5
6
7
8
9
10
Next